Harel Insurance Investments & Financial Services Ltd. reduced its stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 13.3% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 11,800 shares of the semiconductor company’s stock after selling 1,810 shares during the period. Harel Insurance Investments & Financial Services Ltd.’s holdings in Lam Research were worth $2,022,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of the stock. Traphagen Investment Advisors LLC raised its stake in Lam Research by 2.4% in the fourth quarter. Traphagen Investment Advisors LLC now owns 1,963 shares of the semiconductor company’s stock worth $336,000 after buying an additional 46 shares in the last quarter. Field & Main Bank raised its stake in Lam Research by 1.1% in the fourth quarter. Field & Main Bank now owns 4,615 shares of the semiconductor company’s stock worth $790,000 after buying an additional 50 shares in the last quarter. Capital Advisors Ltd. LLC raised its stake in Lam Research by 1.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 4,646 shares of the semiconductor company’s stock worth $795,000 after buying an additional 51 shares in the last quarter. Global Financial Private Client LLC raised its stake in Lam Research by 0.5% in the fourth quarter. Global Financial Private Client LLC now owns 11,037 shares of the semiconductor company’s stock worth $1,889,000 after buying an additional 52 shares in the last quarter. Finally, WealthCollab LLC raised its stake in Lam Research by 29.3% in the fourth quarter. WealthCollab LLC now owns 243 shares of the semiconductor company’s stock worth $42,000 after buying an additional 55 shares in the last quarter. 84.61% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. Citigroup reissued a “buy” rating and issued a $315.00 price target (up from $300.00) on shares of Lam Research in a research note on Thursday, April 23rd. Argus raised their target price on shares of Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. Zacks Research downgraded shares of Lam Research from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Citic Securities raised their target price on shares of Lam Research from $165.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 30th. Finally, Rothschild & Co Redburn raised their target price on shares of Lam Research from $225.00 to $265.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Twenty-six research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and an average target price of $285.94.
Lam Research Price Performance
Shares of NASDAQ LRCX opened at $297.17 on Thursday. Lam Research Corporation has a fifty-two week low of $72.91 and a fifty-two week high of $297.87. The company has a 50 day simple moving average of $238.08 and a two-hundred day simple moving average of $203.95. The company has a market capitalization of $371.63 billion, a price-to-earnings ratio of 56.07, a P/E/G ratio of 2.28 and a beta of 1.81. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.77 and a current ratio of 2.54.
Lam Research (NASDAQ:LRCX – Get Free Report) last announced its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.11. The business had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The business’s revenue for the quarter was up 23.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Analysts expect that Lam Research Corporation will post 5.68 EPS for the current fiscal year.
Lam Research News Summary
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam reported a March-quarter beat and raised June-quarter guidance, signaling accelerating wafer‑fab demand and margin expansion — a primary driver of the rally. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: Wall Street momentum: multiple analysts have raised targets and issued buy/outperform ratings after the print — supporting upside and institutional demand. MarketBeat LRCX analyst coverage
- Positive Sentiment: Seaport Global initiated coverage with a buy, adding to the buy‑side chorus and increasing visibility among fund managers. Seaport Global initiates coverage of Lam Research (LRCX) with buy recommendation
- Positive Sentiment: Sector tailwinds: ETF/sector pieces point to heavy AI infrastructure capex benefiting semiconductor equipment suppliers like Lam. That narrative supports multiple quarters of elevated order flows. Semiconductor Leaders SOXX, SMH, and FTXL Are Crushing It on AI Infrastructure Demand
- Positive Sentiment: Industry capacity constraints (highlighted at KLA) suggest near-term tightness for key tools — reinforcing pricing power and order urgency for suppliers including Lam. KLA’s AI Capacity Constraints Highlight Earnings Power And Buyback Commitment
- Positive Sentiment: Technical/flow drivers: Lam cleared a buy point in IBD coverage after the beat, which can attract momentum and systematic buying. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Broad analyst consensus remains constructive (consensus “Moderate Buy”), which supports continued interest but already embeds much optimism. Lam Research Corporation (NASDAQ:LRCX) Receives Consensus Rating of “Moderate Buy” from Brokerages
- Negative Sentiment: Insider selling: an SVP sold shares under a Rule 10b5‑1 plan; while pre‑planned, the transaction can be viewed negatively by some traders. Insider Selling: Lam Research (NASDAQ:LRCX) SVP Sells 18,170 Shares of Stock
- Negative Sentiment: Valuation cautions: some commentators warn LRCX is approaching frothy levels after the run, which raises pullback risk if guidance or macro signals wobble. Lam Research Is Approaching Frothy Levels
Insider Activity
In related news, Director Eric Brandt sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. This trade represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ava Harter sold 6,010 shares of the firm’s stock in a transaction that occurred on Monday, April 27th. The shares were sold at an average price of $258.66, for a total transaction of $1,554,546.60. Following the sale, the insider directly owned 53,205 shares of the company’s stock, valued at $13,762,005.30. This trade represents a 10.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 155,066 shares of company stock worth $35,849,242 over the last three months. 0.31% of the stock is currently owned by insiders.
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
